Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study

Introduction. The randomized MPACT study showed that nab-paclitaxel plus gemcitabine results in statistically significantly longer life expectancy. The objective of this retrospective study is to obtain relevant data on the efficacy of this combination in real clinical practice in Russia. Materials...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin
Materyal Türü:	Artigo
Dil:	Russo
Baskı/Yayın Bilgisi:	Remedium Group LLC 2019-12-01
Seri Bilgileri:	Медицинский совет
Konular:	pancreatic cancer gemcitabine nab-paclitaxel chemotherapy
Online Erişim:	https://www.med-sovet.pro/jour/article/view/5190
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!